What were Caplin Point Laboratories Ltd's latest quarterly results?
Caplin Point Laboratories Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +18.6%
- Revenue Growth YoY: +10.1%
- Operating Margin: 35.0%
Caplin Point Laboratories Ltd: Stock Analysis & Fundamentals
Updated this weekCaplin Point Laboratories Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. PE: 19.3. ROE: 22.7%. This stock is not currently in the Nifty 500 momentum outperformers list.
What's Happening
📊Debt increased 150% YoY — leverage rising
🌐FII stake increased 2.8% this quarter
Key Numbers
Current Price
₹1,558
Dividend Yield
0.39%
Market Cap
11.8K Cr
Valuation
N/AOther Top Pharma - Formulators Stocks Beating Nifty 500
Frequently Asked Questions: Caplin Point Laboratories Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Caplin Point Laboratories Ltd's current PE ratio?
Caplin Point Laboratories Ltd's current PE ratio is 19.3x.
- Current PE: 19.3x
- Market Cap: 11.8K Cr
- Dividend Yield: 0.39%
What is Caplin Point Laboratories Ltd's price-to-book ratio?
Caplin Point Laboratories Ltd's price-to-book ratio is 3.8x.
- Price-to-Book (P/B): 3.8x
- Book Value per Share: ₹416
- Current Price: ₹1558
Is Caplin Point Laboratories Ltd a fundamentally strong company?
Caplin Point Laboratories Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 26.0%
Is Caplin Point Laboratories Ltd debt free?
Caplin Point Laboratories Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹222 Cr
What is Caplin Point Laboratories Ltd's return on equity (ROE) and ROCE?
Caplin Point Laboratories Ltd's return ratios over recent years
- FY2023: ROCE 26.0%
- FY2024: ROCE 26.0%
- FY2025: ROCE 26.0%
Is Caplin Point Laboratories Ltd's cash flow positive?
Caplin Point Laboratories Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹432 Cr
- Free Cash Flow (FCF): ₹99 Cr
- CFO/PAT Ratio: 80% (strong cash conversion)
What is Caplin Point Laboratories Ltd's dividend yield?
Caplin Point Laboratories Ltd's current dividend yield is 0.39%.
- Dividend Yield: 0.39%
- Current Price: ₹1558
Who holds Caplin Point Laboratories Ltd shares — promoters, FII, DII?
Caplin Point Laboratories Ltd's shareholding pattern (Dec 2025)
- Promoters: 70.6%
- FII (Foreign): 6.6%
- DII (Domestic): 2.0%
- Public: 20.8%
Is promoter holding increasing or decreasing in Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 70.6% (Dec 2025)
- Previous Quarter: 70.6% (Sep 2025)
- Change: 0.00% (stable)
Is Caplin Point Laboratories Ltd a new momentum entry or an established outperformer?
Caplin Point Laboratories Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Caplin Point Laboratories Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Caplin Point Laboratories Ltd may be worth studying
- Cash flow is positive — CFO ₹432 Cr
What is the investment thesis for Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd investment thesis summary:
What is the future outlook for Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.